Recent years have witnessed remarkable advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as potential https://jaysonjugn607750.ambien-blog.com/45716950/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide